Metabolic syndrome and risk of bladder cancer: Prospective cohort study in the metabolic syndrome and cancer project (Me-Can)

International Journal of Cancer

Volumn 128, Issue 8, 2011, Pages 1890-1898

  Häggström, Christel ^a   Stocks, Tanja ^a,b   Rapp, Kilian ^c   Bjørge, Tone ^d,e   Lindkvist, Björn ^f   Concin, Hans ^g   Engeland, Anders ^d,e   Manjer, Jonas ^h   Ulmer, Hanno ⁱ   Selmer, Randi ^e   Tretli, Steinar ^j   Hallmans, Göran ^a   Jonsson, Håkan ^a   Stattin, Pär ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF BERGEN   (Norway)

^e NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

^g AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^j Cancer Registry of Norway   (Norway)

more..

Author keywords

bladder cancer; cohort study; epidemiology; metabolic syndrome

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ARTICLE; AUSTRIA; BLADDER CANCER; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY WEIGHT; CANCER RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ERROR; METABOLIC SYNDROME X; NORWAY; OBESITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SCORING SYSTEM; SWEDEN; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WORLD HEALTH ORGANIZATION;

ADULT; AUSTRIA; BODY MASS INDEX; COHORT STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NORWAY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; URINARY BLADDER NEOPLASMS;

EID: 79951961947     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25521     Document Type: Article

References (49)

1. Parkin D, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
2. Cameron A, Shaw J, Zimmet P,. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004; 33: 351-75. (Pubitemid 38680634)
3. Ford ES, Giles WH, Dietz WH,. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9. (Pubitemid 34251969)
4. Eckel RH, Grundy SM, Zimmet PZ,. The metabolic syndrome. Lancet 2005; 365: 1415-28. (Pubitemid 40523737)
5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT,. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-16. (Pubitemid 35403784)
6. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS,. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004; 109: 42-6. (Pubitemid 38056019)
7. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ,. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-38. (Pubitemid 36459468)
8. Bergstrom A, Pisani P, Tenet V, Wolk A, Adami H,. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001; 91: 421-30. (Pubitemid 32049639)
9. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM,. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202. (Pubitemid 40095870)
10. Stocks T, Rapp K, Bjorge T, Manjer J, Ulmer H, Selmer R, Lukanova A, Johansen D, Concin H, Tretli S, Hallmans G, Jonsson H, et al. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (Me-Can): analysis of six prospective cohorts. PLoS Med 2009; 6: e1000201.
11. Batty GD, Shipley MJ, Jarrett RJ, Breeze E, Marmot MG, Smith GD,. Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. Int J Obes 2005; 29: 1267-74. (Pubitemid 43080307)
12. Cantwell MM, Lacey JV, Jr., Schairer C, Schatzkin A, Michaud DS,. Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study. Int J Cancer 2006; 119: 2398-401. (Pubitemid 44546962)
13. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ,. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004; 159: 1160-7. (Pubitemid 38747263)
14. Grove JS, Nomura A, Severson RK, Stemmermann GN,. The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol 1991; 134: 942-7.
15. Hiatt RA, Fireman BH,. Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis 1986; 39: 861-70. (Pubitemid 17229983)
16. Holick CN, Giovannucci EL, Stampfer MJ, Michaud DS,. Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer 2007; 120: 140-6. (Pubitemid 44910995)
17. Jee SH, Yun JE, Park EJ, Cho ER, Park IS, Sull JW, Ohrr H, Samet JM,. Body mass index and cancer risk in Korean men and women. Int J Cancer 2008; 123: 1892-6.
18. Koebnick C, Michaud D, Moore SC, Park Y, Hollenbeck A, Ballard-Barbash R, Schatzkin A, Leitzmann MF,. Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 2008; 17: 1214-21.
19. Larsson SC, Andersson SO, Johansson JE, Wolk A,. Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer 2008; 44: 2655-60.
20. Morris DL, Borhani NO, Fitzsimons E, Hardy RJ, Hawkins CM, Kraus JF, Labarthe DR, Mastbaum L, Payne GH,. Serum cholesterol and cancer in the Hypertension Detection and Follow-up Program. Cancer 1983; 52: 1754-9. (Pubitemid 13018301)
21. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D,. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335: 1134.
22. Rosengren A, Himmelmann A, Wilhelmsen L, Branehog I, Wedel H,. Hypertension and long-term cancer incidence and mortality among Swedish men. J Hypertens 1998; 16: 933-40. (Pubitemid 28367947)
23. Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF, Jr,. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 2006; 17: 901-9. (Pubitemid 44078281)
24. Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF, Jr,. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 2004; 15: 35-43. (Pubitemid 38339970)
25. Schatzkin A, Hoover RN, Taylor PR, Ziegler RG, Carter CL, Albanes D, Larson DB, Licitra LM,. Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Cancer Res 1988; 48: 452-8. (Pubitemid 18045786)
26. Russo A, Autelitano M, Bisanti L,. Metabolic syndrome and cancer risk. Eur J Cancer 2008; 44: 293-7.
27. Tripathi A, Folsom AR, Anderson KE,. Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer 2002; 95: 2316-23. (Pubitemid 35351137)
28. Goldbohm R, Balder H, van de Bosch L, Preller L, Schouten L, van den Brandt P,. Is body weight associated with risk of bladder cancer? Proc Am Assoc Cancer Res 2006; 2006: B226.
29. Stocks T, Borena W, Strohmaier S, Bjorge T, Manjer J, Engeland A, Johansen D, Selmer R, Hallmans G, Rapp K, Concin H, Jonsson H, et al. Cohort Profile: the metabolic syndrome and cancer project (Me-Can). Int J Epidemiol 2010; 39: 660-7.
30. World Health Organisation. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation; 1999.
31. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i-xii, 1-253.
32. Bland JM, Altman DG,. Multiple significance tests: the Bonferroni method. BMJ 1995; 310: 170.
33. Wood AM, White I, Thompson SG, Lewington S, Danesh J,. Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol 2006; 35: 1570-8.
34. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, Peto R,. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999; 150: 341-53. (Pubitemid 29383482)
35. Emberson JR, Whincup PH, Morris RW, Walker M, Lowe GD, Rumley A,. Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. Eur J Cardiovasc Prev Rehabil 2004; 11: 125-34. (Pubitemid 38591083)
36. Whitlock G, Clark T, Vander Hoorn S, Rodgers A, Jackson R, Norton R, MacMahon S,. Random errors in the measurement of 10 cardiovascular risk factors. Eur J Epidemiol 2001; 17: 907-9. (Pubitemid 34832358)
37. Fibrinogen Studies Collaboration. Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies. Stat Med 2009; 28: 1067-92.
38. Hole DJ, Hawthorne VM, Isles CG, McGhee SM, Robertson JW, Gillis CR, Wapshaw JA, Lever AF,. Incidence of and mortality from cancer in hypertensive patients. BMJ 1993; 306: 609-11. (Pubitemid 23065821)
39. Stumpe KO,. Hypertension and the risk of cancer: is there new evidence? J Hypertens 2002; 20: 565-7. (Pubitemid 34913689)
40. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK,. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 2006; 49: 945-52.
41. Larsson SC, Orsini N, Brismar K, Wolk A,. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 2006; 49: 2819-23. (Pubitemid 44730282)
42. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S,. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006; 166: 1871-7. (Pubitemid 44455170)
43. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW,. Infections in patients with diabetes mellitus. N Engl J Med 1999; 341: 1906-12.
44. Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni JF, Jr,. Urinary tract infection and risk of bladder cancer. Am J Epidemiol 1984; 119: 510-5. (Pubitemid 14134659)
45. Cowey S, Hardy RW,. The metabolic syndrome: a high-risk state for cancer? Am J Pathol 2006; 169: 1505-22. (Pubitemid 351181984)
46. Alberg AJ, Kouzis A, Genkinger JM, Gallicchio L, Burke AE, Hoffman SC, Diener-West M, Helzlsouer KJ, Comstock GW,. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke. Am J Epidemiol 2007; 165: 660-6. (Pubitemid 46348371)
47. Rothman KJ, and, Greenland S, eds. Modern Epidemiology. Pennsylvania: Lippincott, Williams & Wilkins, 1998. 132-134.
48. Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, Moller B,. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009; 45: 1218-31.
49. Sandblom G, Dufmats M, Olsson M, Varenhorst E,. Validity of a population-based cancer register in Sweden-an assessment of data reproducibility in the South-East Region Prostate Cancer Register. Scand J Urol Nephrol 2003; 37: 112-9. (Pubitemid 36535228)